Novel BTK mutation in X-linked agammaglobulinemia: Report of a 17-year-old male

Allergol Immunopathol (Madr). 2021 Mar 1;49(2):80-83. doi: 10.15586/aei.v49i2.62. eCollection 2021.

Abstract

Introduction and objectives: X-linked agammaglobulinemia (XLA), the first known primary immunodeficiency, is caused by rare mutations in Bruton's tyrosine kinase (BTK) gene. Mutations in the BTK gene lead to a failure in the development and maturation of B-cell linage. A decreased number of B-cells results in agammaglobulinemia and increased susceptibility to a variety of infections. Therefore, patients with XLA usually manifest with repetitive bacterial infections, such as upper respiratory tract infections, septic arthritis, osteomyelitis, and urinary tract infections, since their infancy.

Patients: We report a 17-year-old Iranian boy with XLA, referred to us with a history of severe and recurrent episodes of bacterial infections for a period of six years.

Results: Genetic analysis using the whole Exome sequencing revealed a hemizygous missense mutation in the BTK gene (c.428 A > T, p.His143Leu).

Conclusion: To our knowledge, c.428 A > T has not been reported in the BTK gene.

Keywords: X-linked agammaglobulinemia; agammaglobulinemia; immunodeficiency; mutation; tyrosine kinase.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Agammaglobulinaemia Tyrosine Kinase / genetics*
  • Agammaglobulinemia / blood
  • Agammaglobulinemia / diagnosis
  • Agammaglobulinemia / genetics*
  • Agammaglobulinemia / immunology
  • DNA Mutational Analysis
  • Genetic Diseases, X-Linked / blood
  • Genetic Diseases, X-Linked / diagnosis
  • Genetic Diseases, X-Linked / genetics*
  • Genetic Diseases, X-Linked / immunology
  • Genetic Testing
  • Humans
  • Iran
  • Male
  • Mutation, Missense
  • Pedigree

Substances

  • Agammaglobulinaemia Tyrosine Kinase
  • BTK protein, human

Supplementary concepts

  • Bruton type agammaglobulinemia